Global Recombinant Hepatitis B Vaccine Market Insights and Forecast to 2028

Publisher Name :
Date: 05-May-2022
No. of pages: 114
Inquire Before Buying

Recombinant Hepatitis B Vaccine market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Recombinant Hepatitis B Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

- 10mcg/ml

- 10mcg/0.5ml

Segment by Application

- Newborn

- Primary School Students

- Adult

By Company

- Merck

- GlaxoSmithKline Plc

- Pfizer Inc.

- Sanofi Pasteur

- CSL Limited

- Emergent Biosolutions

- Serum Institute of India

- Johnson & Johnson

- Hualan Biological Engineering

- NCPC

- China National Biotec Group

- Dalian Hissen Bio-pharm

- Beijing Tiantan Biological

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

Global Recombinant Hepatitis B Vaccine Market Insights and Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Recombinant Hepatitis B Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Recombinant Hepatitis B Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 10mcg/ml
1.2.3 10mcg/0.5ml
1.3 Market by Application
1.3.1 Global Recombinant Hepatitis B Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Newborn
1.3.3 Primary School Students
1.3.4 Adult
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Recombinant Hepatitis B Vaccine Sales Estimates and Forecasts 2017-2028
2.2 Global Recombinant Hepatitis B Vaccine Revenue Estimates and Forecasts 2017-2028
2.3 Global Recombinant Hepatitis B Vaccine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Recombinant Hepatitis B Vaccine Sales by Region
2.4.1 Global Recombinant Hepatitis B Vaccine Sales by Region (2017-2022)
2.4.2 Global Sales Recombinant Hepatitis B Vaccine by Region (2023-2028)
2.5 Global Recombinant Hepatitis B Vaccine Revenue by Region
2.5.1 Global Recombinant Hepatitis B Vaccine Revenue by Region (2017-2022)
2.5.2 Global Recombinant Hepatitis B Vaccine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Recombinant Hepatitis B Vaccine Sales by Manufacturers
3.1.1 Global Top Recombinant Hepatitis B Vaccine Manufacturers by Sales (2017-2022)
3.1.2 Global Recombinant Hepatitis B Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Recombinant Hepatitis B Vaccine in 2021
3.2 Global Recombinant Hepatitis B Vaccine Revenue by Manufacturers
3.2.1 Global Recombinant Hepatitis B Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Global Recombinant Hepatitis B Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Recombinant Hepatitis B Vaccine Revenue in 2021
3.3 Global Recombinant Hepatitis B Vaccine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Recombinant Hepatitis B Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Recombinant Hepatitis B Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Recombinant Hepatitis B Vaccine Sales by Type
4.1.1 Global Recombinant Hepatitis B Vaccine Historical Sales by Type (2017-2022)
4.1.2 Global Recombinant Hepatitis B Vaccine Forecasted Sales by Type (2023-2028)
4.1.3 Global Recombinant Hepatitis B Vaccine Sales Market Share by Type (2017-2028)
4.2 Global Recombinant Hepatitis B Vaccine Revenue by Type
4.2.1 Global Recombinant Hepatitis B Vaccine Historical Revenue by Type (2017-2022)
4.2.2 Global Recombinant Hepatitis B Vaccine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Recombinant Hepatitis B Vaccine Revenue Market Share by Type (2017-2028)
4.3 Global Recombinant Hepatitis B Vaccine Price by Type
4.3.1 Global Recombinant Hepatitis B Vaccine Price by Type (2017-2022)
4.3.2 Global Recombinant Hepatitis B Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Recombinant Hepatitis B Vaccine Sales by Application
5.1.1 Global Recombinant Hepatitis B Vaccine Historical Sales by Application (2017-2022)
5.1.2 Global Recombinant Hepatitis B Vaccine Forecasted Sales by Application (2023-2028)
5.1.3 Global Recombinant Hepatitis B Vaccine Sales Market Share by Application (2017-2028)
5.2 Global Recombinant Hepatitis B Vaccine Revenue by Application
5.2.1 Global Recombinant Hepatitis B Vaccine Historical Revenue by Application (2017-2022)
5.2.2 Global Recombinant Hepatitis B Vaccine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Recombinant Hepatitis B Vaccine Revenue Market Share by Application (2017-2028)
5.3 Global Recombinant Hepatitis B Vaccine Price by Application
5.3.1 Global Recombinant Hepatitis B Vaccine Price by Application (2017-2022)
5.3.2 Global Recombinant Hepatitis B Vaccine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Recombinant Hepatitis B Vaccine Market Size by Type
6.1.1 North America Recombinant Hepatitis B Vaccine Sales by Type (2017-2028)
6.1.2 North America Recombinant Hepatitis B Vaccine Revenue by Type (2017-2028)
6.2 North America Recombinant Hepatitis B Vaccine Market Size by Application
6.2.1 North America Recombinant Hepatitis B Vaccine Sales by Application (2017-2028)
6.2.2 North America Recombinant Hepatitis B Vaccine Revenue by Application (2017-2028)
6.3 North America Recombinant Hepatitis B Vaccine Market Size by Country
6.3.1 North America Recombinant Hepatitis B Vaccine Sales by Country (2017-2028)
6.3.2 North America Recombinant Hepatitis B Vaccine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Recombinant Hepatitis B Vaccine Market Size by Type
7.1.1 Europe Recombinant Hepatitis B Vaccine Sales by Type (2017-2028)
7.1.2 Europe Recombinant Hepatitis B Vaccine Revenue by Type (2017-2028)
7.2 Europe Recombinant Hepatitis B Vaccine Market Size by Application
7.2.1 Europe Recombinant Hepatitis B Vaccine Sales by Application (2017-2028)
7.2.2 Europe Recombinant Hepatitis B Vaccine Revenue by Application (2017-2028)
7.3 Europe Recombinant Hepatitis B Vaccine Market Size by Country
7.3.1 Europe Recombinant Hepatitis B Vaccine Sales by Country (2017-2028)
7.3.2 Europe Recombinant Hepatitis B Vaccine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Recombinant Hepatitis B Vaccine Market Size by Type
8.1.1 Asia Pacific Recombinant Hepatitis B Vaccine Sales by Type (2017-2028)
8.1.2 Asia Pacific Recombinant Hepatitis B Vaccine Revenue by Type (2017-2028)
8.2 Asia Pacific Recombinant Hepatitis B Vaccine Market Size by Application
8.2.1 Asia Pacific Recombinant Hepatitis B Vaccine Sales by Application (2017-2028)
8.2.2 Asia Pacific Recombinant Hepatitis B Vaccine Revenue by Application (2017-2028)
8.3 Asia Pacific Recombinant Hepatitis B Vaccine Market Size by Region
8.3.1 Asia Pacific Recombinant Hepatitis B Vaccine Sales by Region (2017-2028)
8.3.2 Asia Pacific Recombinant Hepatitis B Vaccine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Recombinant Hepatitis B Vaccine Market Size by Type
9.1.1 Latin America Recombinant Hepatitis B Vaccine Sales by Type (2017-2028)
9.1.2 Latin America Recombinant Hepatitis B Vaccine Revenue by Type (2017-2028)
9.2 Latin America Recombinant Hepatitis B Vaccine Market Size by Application
9.2.1 Latin America Recombinant Hepatitis B Vaccine Sales by Application (2017-2028)
9.2.2 Latin America Recombinant Hepatitis B Vaccine Revenue by Application (2017-2028)
9.3 Latin America Recombinant Hepatitis B Vaccine Market Size by Country
9.3.1 Latin America Recombinant Hepatitis B Vaccine Sales by Country (2017-2028)
9.3.2 Latin America Recombinant Hepatitis B Vaccine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Recombinant Hepatitis B Vaccine Market Size by Type
10.1.1 Middle East and Africa Recombinant Hepatitis B Vaccine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Recombinant Hepatitis B Vaccine Revenue by Type (2017-2028)
10.2 Middle East and Africa Recombinant Hepatitis B Vaccine Market Size by Application
10.2.1 Middle East and Africa Recombinant Hepatitis B Vaccine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Recombinant Hepatitis B Vaccine Revenue by Application (2017-2028)
10.3 Middle East and Africa Recombinant Hepatitis B Vaccine Market Size by Country
10.3.1 Middle East and Africa Recombinant Hepatitis B Vaccine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Recombinant Hepatitis B Vaccine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Overview
11.1.3 Merck Recombinant Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Merck Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 GlaxoSmithKline Plc
11.2.1 GlaxoSmithKline Plc Corporation Information
11.2.2 GlaxoSmithKline Plc Overview
11.2.3 GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GlaxoSmithKline Plc Recent Developments
11.3 Pfizer Inc.
11.3.1 Pfizer Inc. Corporation Information
11.3.2 Pfizer Inc. Overview
11.3.3 Pfizer Inc. Recombinant Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Pfizer Inc. Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Pfizer Inc. Recent Developments
11.4 Sanofi Pasteur
11.4.1 Sanofi Pasteur Corporation Information
11.4.2 Sanofi Pasteur Overview
11.4.3 Sanofi Pasteur Recombinant Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Sanofi Pasteur Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sanofi Pasteur Recent Developments
11.5 CSL Limited
11.5.1 CSL Limited Corporation Information
11.5.2 CSL Limited Overview
11.5.3 CSL Limited Recombinant Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 CSL Limited Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 CSL Limited Recent Developments
11.6 Emergent Biosolutions
11.6.1 Emergent Biosolutions Corporation Information
11.6.2 Emergent Biosolutions Overview
11.6.3 Emergent Biosolutions Recombinant Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Emergent Biosolutions Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Emergent Biosolutions Recent Developments
11.7 Serum Institute of India
11.7.1 Serum Institute of India Corporation Information
11.7.2 Serum Institute of India Overview
11.7.3 Serum Institute of India Recombinant Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Serum Institute of India Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Serum Institute of India Recent Developments
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Corporation Information
11.8.2 Johnson & Johnson Overview
11.8.3 Johnson & Johnson Recombinant Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Johnson & Johnson Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Johnson & Johnson Recent Developments
11.9 Hualan Biological Engineering
11.9.1 Hualan Biological Engineering Corporation Information
11.9.2 Hualan Biological Engineering Overview
11.9.3 Hualan Biological Engineering Recombinant Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Hualan Biological Engineering Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Hualan Biological Engineering Recent Developments
11.10 NCPC
11.10.1 NCPC Corporation Information
11.10.2 NCPC Overview
11.10.3 NCPC Recombinant Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 NCPC Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 NCPC Recent Developments
11.11 China National Biotec Group
11.11.1 China National Biotec Group Corporation Information
11.11.2 China National Biotec Group Overview
11.11.3 China National Biotec Group Recombinant Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 China National Biotec Group Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 China National Biotec Group Recent Developments
11.12 Dalian Hissen Bio-pharm
11.12.1 Dalian Hissen Bio-pharm Corporation Information
11.12.2 Dalian Hissen Bio-pharm Overview
11.12.3 Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Dalian Hissen Bio-pharm Recent Developments
11.13 Beijing Tiantan Biological
11.13.1 Beijing Tiantan Biological Corporation Information
11.13.2 Beijing Tiantan Biological Overview
11.13.3 Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Beijing Tiantan Biological Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Recombinant Hepatitis B Vaccine Industry Chain Analysis
12.2 Recombinant Hepatitis B Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Recombinant Hepatitis B Vaccine Production Mode & Process
12.4 Recombinant Hepatitis B Vaccine Sales and Marketing
12.4.1 Recombinant Hepatitis B Vaccine Sales Channels
12.4.2 Recombinant Hepatitis B Vaccine Distributors
12.5 Recombinant Hepatitis B Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Recombinant Hepatitis B Vaccine Industry Trends
13.2 Recombinant Hepatitis B Vaccine Market Drivers
13.3 Recombinant Hepatitis B Vaccine Market Challenges
13.4 Recombinant Hepatitis B Vaccine Market Restraints
14 Key Findings in The Global Recombinant Hepatitis B Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Recombinant Hepatitis B Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 10mcg/ml
Table 3. Major Manufacturers of 10mcg/0.5ml
Table 4. Global Recombinant Hepatitis B Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Recombinant Hepatitis B Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Recombinant Hepatitis B Vaccine Sales by Region (2017-2022) & (K Units)
Table 7. Global Recombinant Hepatitis B Vaccine Sales Market Share by Region (2017-2022)
Table 8. Global Recombinant Hepatitis B Vaccine Sales by Region (2023-2028) & (K Units)
Table 9. Global Recombinant Hepatitis B Vaccine Sales Market Share by Region (2023-2028)
Table 10. Global Recombinant Hepatitis B Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Region (2017-2022)
Table 12. Global Recombinant Hepatitis B Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Region (2023-2028)
Table 14. Global Recombinant Hepatitis B Vaccine Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Recombinant Hepatitis B Vaccine Sales Share by Manufacturers (2017-2022)
Table 16. Global Recombinant Hepatitis B Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Recombinant Hepatitis B Vaccine Revenue Share by Manufacturers (2017-2022)
Table 18. Recombinant Hepatitis B Vaccine Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Recombinant Hepatitis B Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Recombinant Hepatitis B Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Hepatitis B Vaccine as of 2021)
Table 21. Recombinant Hepatitis B Vaccine Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Recombinant Hepatitis B Vaccine Product Offered
Table 23. Date of Manufacturers Enter into Recombinant Hepatitis B Vaccine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Recombinant Hepatitis B Vaccine Sales by Type (2017-2022) & (K Units)
Table 26. Global Recombinant Hepatitis B Vaccine Sales by Type (2023-2028) & (K Units)
Table 27. Global Recombinant Hepatitis B Vaccine Sales Share by Type (2017-2022)
Table 28. Global Recombinant Hepatitis B Vaccine Sales Share by Type (2023-2028)
Table 29. Global Recombinant Hepatitis B Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Recombinant Hepatitis B Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Recombinant Hepatitis B Vaccine Revenue Share by Type (2017-2022)
Table 32. Global Recombinant Hepatitis B Vaccine Revenue Share by Type (2023-2028)
Table 33. Recombinant Hepatitis B Vaccine Price by Type (2017-2022) & (US$/Unit)
Table 34. Global Recombinant Hepatitis B Vaccine Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global Recombinant Hepatitis B Vaccine Sales by Application (2017-2022) & (K Units)
Table 36. Global Recombinant Hepatitis B Vaccine Sales by Application (2023-2028) & (K Units)
Table 37. Global Recombinant Hepatitis B Vaccine Sales Share by Application (2017-2022)
Table 38. Global Recombinant Hepatitis B Vaccine Sales Share by Application (2023-2028)
Table 39. Global Recombinant Hepatitis B Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Recombinant Hepatitis B Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Recombinant Hepatitis B Vaccine Revenue Share by Application (2017-2022)
Table 42. Global Recombinant Hepatitis B Vaccine Revenue Share by Application (2023-2028)
Table 43. Recombinant Hepatitis B Vaccine Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Recombinant Hepatitis B Vaccine Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Recombinant Hepatitis B Vaccine Sales by Type (2017-2022) & (K Units)
Table 46. North America Recombinant Hepatitis B Vaccine Sales by Type (2023-2028) & (K Units)
Table 47. North America Recombinant Hepatitis B Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Recombinant Hepatitis B Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Recombinant Hepatitis B Vaccine Sales by Application (2017-2022) & (K Units)
Table 50. North America Recombinant Hepatitis B Vaccine Sales by Application (2023-2028) & (K Units)
Table 51. North America Recombinant Hepatitis B Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Recombinant Hepatitis B Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Recombinant Hepatitis B Vaccine Sales by Country (2017-2022) & (K Units)
Table 54. North America Recombinant Hepatitis B Vaccine Sales by Country (2023-2028) & (K Units)
Table 55. North America Recombinant Hepatitis B Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Recombinant Hepatitis B Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Recombinant Hepatitis B Vaccine Sales by Type (2017-2022) & (K Units)
Table 58. Europe Recombinant Hepatitis B Vaccine Sales by Type (2023-2028) & (K Units)
Table 59. Europe Recombinant Hepatitis B Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Recombinant Hepatitis B Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Recombinant Hepatitis B Vaccine Sales by Application (2017-2022) & (K Units)
Table 62. Europe Recombinant Hepatitis B Vaccine Sales by Application (2023-2028) & (K Units)
Table 63. Europe Recombinant Hepatitis B Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Recombinant Hepatitis B Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Recombinant Hepatitis B Vaccine Sales by Country (2017-2022) & (K Units)
Table 66. Europe Recombinant Hepatitis B Vaccine Sales by Country (2023-2028) & (K Units)
Table 67. Europe Recombinant Hepatitis B Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Recombinant Hepatitis B Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Recombinant Hepatitis B Vaccine Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Recombinant Hepatitis B Vaccine Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Recombinant Hepatitis B Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Recombinant Hepatitis B Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Recombinant Hepatitis B Vaccine Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Recombinant Hepatitis B Vaccine Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Recombinant Hepatitis B Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Recombinant Hepatitis B Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Recombinant Hepatitis B Vaccine Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Recombinant Hepatitis B Vaccine Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Recombinant Hepatitis B Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Recombinant Hepatitis B Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Recombinant Hepatitis B Vaccine Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Recombinant Hepatitis B Vaccine Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Recombinant Hepatitis B Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Recombinant Hepatitis B Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Recombinant Hepatitis B Vaccine Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Recombinant Hepatitis B Vaccine Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Recombinant Hepatitis B Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Recombinant Hepatitis B Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Recombinant Hepatitis B Vaccine Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Recombinant Hepatitis B Vaccine Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Recombinant Hepatitis B Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Recombinant Hepatitis B Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Recombinant Hepatitis B Vaccine Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Recombinant Hepatitis B Vaccine Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Recombinant Hepatitis B Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Recombinant Hepatitis B Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Recombinant Hepatitis B Vaccine Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Recombinant Hepatitis B Vaccine Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Recombinant Hepatitis B Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Recombinant Hepatitis B Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Recombinant Hepatitis B Vaccine Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Recombinant Hepatitis B Vaccine Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Recombinant Hepatitis B Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Recombinant Hepatitis B Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 105. Merck Corporation Information
Table 106. Merck Description and Major Businesses
Table 107. Merck Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. Merck Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Merck Recent Developments
Table 110. GlaxoSmithKline Plc Corporation Information
Table 111. GlaxoSmithKline Plc Description and Major Businesses
Table 112. GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. GlaxoSmithKline Plc Recent Developments
Table 115. Pfizer Inc. Corporation Information
Table 116. Pfizer Inc. Description and Major Businesses
Table 117. Pfizer Inc. Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. Pfizer Inc. Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Pfizer Inc. Recent Developments
Table 120. Sanofi Pasteur Corporation Information
Table 121. Sanofi Pasteur Description and Major Businesses
Table 122. Sanofi Pasteur Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. Sanofi Pasteur Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Sanofi Pasteur Recent Developments
Table 125. CSL Limited Corporation Information
Table 126. CSL Limited Description and Major Businesses
Table 127. CSL Limited Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 128. CSL Limited Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. CSL Limited Recent Developments
Table 130. Emergent Biosolutions Corporation Information
Table 131. Emergent Biosolutions Description and Major Businesses
Table 132. Emergent Biosolutions Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 133. Emergent Biosolutions Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Emergent Biosolutions Recent Developments
Table 135. Serum Institute of India Corporation Information
Table 136. Serum Institute of India Description and Major Businesses
Table 137. Serum Institute of India Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 138. Serum Institute of India Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Serum Institute of India Recent Developments
Table 140. Johnson & Johnson Corporation Information
Table 141. Johnson & Johnson Description and Major Businesses
Table 142. Johnson & Johnson Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 143. Johnson & Johnson Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Johnson & Johnson Recent Developments
Table 145. Hualan Biological Engineering Corporation Information
Table 146. Hualan Biological Engineering Description and Major Businesses
Table 147. Hualan Biological Engineering Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 148. Hualan Biological Engineering Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Hualan Biological Engineering Recent Developments
Table 150. NCPC Corporation Information
Table 151. NCPC Description and Major Businesses
Table 152. NCPC Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 153. NCPC Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. NCPC Recent Developments
Table 155. China National Biotec Group Corporation Information
Table 156. China National Biotec Group Description and Major Businesses
Table 157. China National Biotec Group Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 158. China National Biotec Group Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. China National Biotec Group Recent Developments
Table 160. Dalian Hissen Bio-pharm Corporation Information
Table 161. Dalian Hissen Bio-pharm Description and Major Businesses
Table 162. Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 163. Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Dalian Hissen Bio-pharm Recent Developments
Table 165. Beijing Tiantan Biological Corporation Information
Table 166. Beijing Tiantan Biological Description and Major Businesses
Table 167. Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 168. Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Beijing Tiantan Biological Recent Developments
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Recombinant Hepatitis B Vaccine Distributors List
Table 173. Recombinant Hepatitis B Vaccine Custo
  • Global Megestrol Acetate (Megace) Market Research Report 2022
    Published: 18-Aug-2022        Price: US 2900 Onwards        Pages: 96
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Suspension - Tablets Segment by Application - Hospital - Clinic - Other ......
  • Global Oxcarbazepine Tablets Market Research Report 2022
    Published: 18-Aug-2022        Price: US 2900 Onwards        Pages: 116
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Tablets (150mg) - Tablets (300mg) - Tablets (600mg) Segment by Application - Hospital......
  • Global Oxcarbazepine API Market Research Report 2022
    Published: 18-Aug-2022        Price: US 2900 Onwards        Pages: 116
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Medical Grade - Other Segment by Application - Tablets - Oral Suspension - Oth......
  • Global Therapeutic Dog Food Market Research Report 2022
    Published: 18-Aug-2022        Price: US 2900 Onwards        Pages: 100
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Dry Food - Wet/Canned Food - Fresh Food - Snacks/treats - Others Segment by Ap......
  • Global Transtympanic Injectable Market Research Report 2022
    Published: 18-Aug-2022        Price: US 2900 Onwards        Pages: 90
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Corticosteroid - Aminoglycosides Segment by Application - Hospitals - ENT Clinics......
  • Global Enzyme Indicators Market Research Report 2022
    Published: 18-Aug-2022        Price: US 2900 Onwards        Pages: 119
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Bio-decontamination - Drug Development - Pesticide Synthesis Segment by Application -......
  • Global Stool Softeners Market Research Report 2022
    Published: 18-Aug-2022        Price: US 2900 Onwards        Pages: 102
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Liquid - Softgel Capsule - Enema Segment by Application - Hospitals - Clinics......
  • Global Std Self Diagnostics Market Research Report 2022
    Published: 18-Aug-2022        Price: US 2900 Onwards        Pages: 94
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Testing Kit - Testing Device - Testing Strip/chip Segment by Application - Hospitals......
  • Global Eye Drops for Contact Lens Market Research Report 2022
    Published: 18-Aug-2022        Price: US 2900 Onwards        Pages: 99
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - = 10ml - > 10ml Segment by Application - Online Channel - Offline Channel ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs